Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 113301-113350 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT06406556
Safety & Efficacy of Peg-ASP-based CCRT in Early Stage ENKTL
PHASE2
Recruiting
90 participants
Started: Mar 1, 2016 · Completed: Mar 1, 2026
1 condition
1 sponsor
1 location
NCT05926284
Prospective Observational Study of a Precision Medicine Approach in Patients With Advanced Cancer
N/A
Recruiting
2,000 participants
Started: Mar 1, 2016 · Completed: Mar 1, 2031
1 condition
1 sponsor
1 location
NCT02673333
Single Agent Pembrolizumab in Subjects With Advanced Adrenocortical Carcinoma
PHASE2
Active, not recruiting
39 participants
Started: Feb 29, 2016 · Completed: Feb 28, 2026
1 condition
2 sponsors
2 locations
NCT02689648
Long Term Follow up on Functional Gastrointestinal Disorder (FGID)
N/A
Active, not recruiting
400 participants
Started: Feb 29, 2016 · Completed: Jan 31, 2027
1 condition
1 sponsor
1 location
NCT02725060
Autoimmune Basis for Postural Tachycardia Syndrome
NA
Enrolling by invitation
58 participants
Started: Feb 29, 2016 · Completed: Dec 31, 2025
8 conditions
2 sponsors
2 locations
NCT02524405
BEAM: Brain-Eye Amyloid Memory Study
N/A
Recruiting
345 participants
Started: Feb 29, 2016 · Completed: Mar 31, 2025
5 conditions
9 sponsors
5 locations
NCT02692807
Arthroscopic Surgical Procedures vs Sham Surgery for Patients With Femoroacetabular Impingement and/or Labral Tears.
NA
Active, not recruiting
140 participants
Started: Feb 29, 2016 · Completed: Dec 31, 2035
1 condition
6 sponsors
2 locations
NCT02766231
Physica CR and Physica PS Clinical Trial
N/A
Active, not recruiting
157 participants
Started: Feb 29, 2016 · Completed: Jun 30, 2028
1 condition
1 sponsor
4 locations
NCT02677051
Sulforaphane in a New Jersey (NJ) Population of Individuals With Autism
PHASE2
Active, not recruiting
48 participants
Started: Feb 29, 2016 · Completed: Jul 31, 2025
4 conditions
2 sponsors
1 location
NCT02697396
Trial of a Social Marketing Campaign to Increase HPV Vaccination Among Mexican American Children
N/A
Active, not recruiting
181 participants
Started: Feb 29, 2016 · Completed: Feb 28, 2026
1 condition
3 sponsors
1 location
NCT02681211
Auricular Acupuncture vs SOC in Migraine HA
NA
Recruiting
80 participants
Started: Feb 29, 2016 · Completed: Nov 30, 2024
1 condition
1 sponsor
2 locations
NCT02688959
Motor Attention Training for Attention Deficit Hyperactivity Disorder (ADHD)
NA
Recruiting
145 participants
Started: Feb 29, 2016 · Completed: Dec 31, 2028
1 condition
1 sponsor
1 location
NCT02679144
Neuroblastoma Maintenance Therapy Trial
PHASE2
Recruiting
441 participants
Started: Feb 29, 2016 · Completed: Feb 28, 2033
1 condition
3 sponsors
47 locations
NCT02664337
Conjoint Analysis of Patient Preferences in Joint Interventions
NA
Enrolling by invitation
2,310 participants
Started: Feb 29, 2016 · Completed: Jul 31, 2027
6 conditions
1 sponsor
1 location
NCT02678962
Comparison of Outcomes With Multifocal Intraocular Lenses
NA
Recruiting
90 participants
Started: Feb 29, 2016 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT02357797
Adjunctive Vortioxetine in Schizophrenia
PHASE4
Active, not recruiting
88 participants
Started: Feb 29, 2016 · Completed: Jun 1, 2024
2 conditions
2 sponsors
3 locations
NCT02673931
GLP-1 and Hyperoxia for Organ Protection in Heart Surgery
NA
Active, not recruiting
1,400 participants
Started: Feb 29, 2016 · Completed: Sep 30, 2024
6 conditions
1 sponsor
1 location
NCT02491697
Immunotherapy Combined With Capecitabine Versus Capecitabine Monotherapy in Advanced Breast Cancer
PHASE2
Active, not recruiting
400 participants
Started: Feb 29, 2016 · Completed: Aug 31, 2033
1 condition
1 sponsor
0 locations
NCT02706704
Intravitreal Adalimumab Versus Subcutaneous Adalimumab in Non-infectious Uveitis
PHASE2
Recruiting
32 participants
Started: Feb 29, 2016 · Completed: Feb 28, 2026
2 conditions
1 sponsor
1 location
NCT02646475
Metabolic Effects of Angiotensin-(1-7)
PHASE1
Recruiting
26 participants
Started: Feb 29, 2016 · Completed: Dec 31, 2029
4 conditions
1 sponsor
1 location
NCT02597348
Liver Transplantation in Patients With Unresectable Colorectal Liver Metastases Treated by Chemotherapy
NA
Active, not recruiting
94 participants
Started: Feb 29, 2016 · Completed: Jul 31, 2026
3 conditions
1 sponsor
1 location
NCT02701829
Taxi METERS: Measuring Effectiveness of Technology, Education, Referrals and Support
NA
Active, not recruiting
166 participants
Started: Feb 29, 2016 · Completed: Feb 28, 2026
1 condition
1 sponsor
1 location
NCT02677064
Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia
N/A
Recruiting
1,365 participants
Started: Feb 29, 2016 · Completed: Feb 28, 2026
3 conditions
1 sponsor
3 locations
NCT03011398
A Clinical Registry of Orthobiologics Procedures
N/A
Enrolling by invitation
50,000 participants
Started: Feb 29, 2016 · Completed: Feb 29, 2036
1 condition
1 sponsor
32 locations
NCT02494167
Administration of Donor Multi TAA-Specific T Cells for AML or MDS (ADSPAM)
PHASE1
Active, not recruiting
44 participants
Started: Feb 29, 2016 · Completed: Feb 28, 2027
2 conditions
5 sponsors
2 locations
NCT02706262
Complex Effects of Dietary Manipulation on Metabolic Function, Inflammation and Health
NA
Active, not recruiting
180 participants
Started: Feb 29, 2016 · Completed: Dec 31, 2027
2 conditions
1 sponsor
1 location
NCT02726061
Internet Based Psychological Support
NA
Recruiting
500 participants
Started: Feb 29, 2016 · Completed: Feb 28, 2031
3 conditions
1 sponsor
1 location
NCT02734069
Impact of Fat-free Mass in the Carboplatin Calculated Dose and Chemotherapeutic Toxicity in Patients With Advanced NSCLC
N/A
Recruiting
132 participants
Started: Feb 29, 2016 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
NCT02465307
Intelligent Intensive Care Unit
N/A
Active, not recruiting
130 participants
Started: Feb 29, 2016 · Completed: May 30, 2028
2 conditions
4 sponsors
1 location
NCT02986243
Preparing for Kidney Transplant by Attaining a Healthy Weight
NA
Active, not recruiting
10 participants
Started: Feb 29, 2016 · Completed: Nov 30, 2025
1 condition
1 sponsor
0 locations
NCT02676973
Apical Suspension Repair for Vault Prolapse In a Three-Arm Randomized Trial Design
NA
Active, not recruiting
360 participants
Started: Feb 29, 2016 · Completed: Dec 31, 2026
1 condition
13 sponsors
10 locations
NCT02691338
Monitoring Neurological Deterioration in Anaesthetised Patients With Electroencephalogram (EEG)
N/A
Recruiting
150 participants
Started: Feb 29, 2016 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT02799537
Comparing the Stanford Letter Project Form to Traditional Advance Directives
NA
Recruiting
1,000 participants
Started: Feb 29, 2016 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT02817360
NT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients
PHASE4
Recruiting
2,400 participants
Started: Feb 29, 2016 · Completed: Dec 31, 2026
2 conditions
1 sponsor
21 locations
NCT02678299
Phase 1/2 Study of the Combination of Pixantrone, Etoposide, Bendamustine and, in CD20 Positive Tumors, Rituximab in Patients With Relapsed Aggressive Non-Hodgkin Lymphomas of B- or T-cell Phenotype - the P[R]EBEN Study
PHASE1/PHASE2
Active, not recruiting
60 participants
Started: Feb 29, 2016 · Completed: Dec 31, 2025
1 condition
1 sponsor
18 locations
NCT02611453
Cholangiography Using Carbon Dioxide Versus Iodinated Contrast in ERCP
NA
Active, not recruiting
40 participants
Started: Feb 29, 2016 · Completed: Dec 31, 2024
3 conditions
1 sponsor
1 location
NCT02735824
Genetic Study of Immunodeficiency: Search for New Genetic Causes for Primary Immunodeficiencies
N/A
Recruiting
500 participants
Started: Feb 29, 2016 · Completed: Dec 31, 2027
1 condition
3 sponsors
2 locations
NCT02603341
Pragmatic Randomized Trial of Proton Vs. Photon Therapy for Patients with Non-Metastatic Breast Cancer: a Radiotherapy Comparative Effectiveness (RADCOMP) Consortium Trial
NA
Active, not recruiting
1,238 participants
Started: Feb 29, 2016 · Completed: Nov 30, 2036
1 condition
2 sponsors
40 locations
NCT05982574
Tumor Microenvironment
N/A
Active, not recruiting
300 participants
Started: Feb 29, 2016 · Completed: Dec 31, 2026
1 condition
1 sponsor
0 locations
NCT02617004
Multicenter Trial Treatment of Philadelphia Chromosome Negative B-cell Acute Lymphoblastic Leukemia of Young Adults
N/A
Recruiting
500 participants
Started: Feb 29, 2016 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT02701712
Receiving Radiation Therapy in the MRgRT Research Facility
NA
Recruiting
150 participants
Started: Feb 29, 2016 · Completed: Feb 28, 2025
1 condition
1 sponsor
1 location
NCT02693990
A Trial of Increased Dose Intensity Modulated Proton Therapy (IMPT) for High-Grade Meningiomas
NA
Active, not recruiting
21 participants
Started: Feb 29, 2016 · Completed: Aug 31, 2027
2 conditions
2 sponsors
2 locations
NCT02489890
CIK in Treating Patients With Bladder Cancer
PHASE2
Active, not recruiting
1,500 participants
Started: Feb 29, 2016 · Completed: Jul 31, 2030
1 condition
1 sponsor
0 locations
NCT02710370
Intestinal Metabolic Reprogramming as a Key Mechanism of Gastric Bypass in Humans
N/A
Active, not recruiting
46 participants
Started: Feb 29, 2016 · Completed: Aug 31, 2028
5 conditions
4 sponsors
1 location
NCT02675829
Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant Cancers
PHASE2
Active, not recruiting
131 participants
Started: Feb 29, 2016 · Completed: Feb 28, 2026
4 conditions
2 sponsors
7 locations
NCT02811523
In Vivo Lung Perfusion for Pulmonary Metastases of Sarcoma
PHASE1
Recruiting
17 participants
Started: Feb 29, 2016 · Completed: Sep 30, 2025
3 conditions
1 sponsor
1 location
NCT02649647
Proximally Extended Resection for Rectal Cancer After Neoadjuvant Chemoradiotherapy
NA
Recruiting
240 participants
Started: Feb 29, 2016 · Completed: Dec 31, 2028
1 condition
3 sponsors
1 location
NCT02623972
A Phase 2 Study of Eribulin Followed by AC as Preoperative Therapy for HER2-negative Inflammatory Breast Cancer
PHASE2
Active, not recruiting
22 participants
Started: Feb 26, 2016 · Completed: Dec 31, 2026
2 conditions
2 sponsors
2 locations
NCT02791854
Improving the Quality of Care for Adults With Inflammatory Bowel Disease
N/A
Enrolling by invitation
10,000 participants
Started: Feb 26, 2016 · Completed: Dec 31, 2030
3 conditions
4 sponsors
29 locations
NCT02925221
Canadian Medical Assessment of JINARC™ Outcomes Registry
N/A
Recruiting
530 participants
Started: Feb 26, 2016 · Completed: Dec 31, 2025
1 condition
1 sponsor
6 locations
Previous
1
More pages
2264
2265
2266
2267
2268
2269
2270
More pages
2369
Next